Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux (Q44272957)

1 December 2017

Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux (English)

1 reference

1 December 2017

1 reference

2

1 reference

1 December 2017

Arnold von Eckardstein

1

object named as

Arnold von Eckardstein

1 reference

1 December 2017

Jolanda Elbers

3

1 reference

1 December 2017

Jennifer Ragoobir

4

1 reference

1 December 2017

Benjamin Ezeh

5

1 reference

1 December 2017

Frans Helmond

6

1 reference

1 December 2017

Norman Miller

7

1 reference

1 December 2017

Hans Dieplinger

8

1 reference

1 December 2017

Herjan Coelingh Bennink

9

1 reference

1 December 2017

Gerd Assmann

10

1 reference

1 December 2017

1 January 2003

1 reference

1 December 2017

Clinical Endocrinology

1 reference

1 December 2017

58

1 reference

1 December 2017

49-58

1 reference

1 December 2017

1

1 reference

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

1 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Tibolone: a steroid with a tissue-specific mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

The role of hormone replacement therapy in the prevention of postmenopausal heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

HDL and arteriosclerosis: beyond reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Hormone replacement therapy and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Remodelling of high density lipoproteins by plasma factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01666.X

10.1046/J.1365-2265.2003.01666.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference